CMS mandates registry data for coverage of Alzheimer’s drugs
CMS announced that it will cover Eisai's Leqembi, upon a traditional approval, if physicians enter patient data into registries.

CMS announced that it will cover Eisai's Leqembi, upon a traditional approval, if physicians enter patient data into registries.
XtalPi brings together AI “dry lab” algorithms and “wet lab” robotics to drive innovation.
In the European pharmaceutical industry, there were 15 private equity deals announced in Q1 2023, worth a total value of…
University of Sydney will use AI to boost cancer drug research
SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine
Medsenic amends licence agreement with Phebra for arsenic trioxide
Novavax receives positive opinion from CHMP for full MA of Covid vaccine